{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T02:19:27Z","timestamp":1787019567537,"version":"build-2736575974"},"reference-count":23,"publisher":"American Society of Hematology","issue":"4","content-domain":{"domain":["ashpublications.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2002,2,15]]},"abstract":"<jats:p>Treatment of severe, chronic idiopathic thrombocytopenic purpura (ITP) refractory to most usual therapies is a difficult challenge. Little information exists on the clinical use of cyclosporin A (CyA) in the treatment of ITP. This report describes long-term treatment with CyA (median, 40 months) and follow-up (median, 36.8 months) in 12 adult patients with resistant ITP. CyA used in relatively low doses (2.5-3 mg\/kg of body weight per day) led to a clinical improvement in 10 patients (83.3%). Five had a complete response (41.1%), 4 a complete response to maintenance therapy (33.3%), and one a partial response (8.3%). Two patients had no response. Most patients with a response (60%) had a long-term remission (mean, 28.6 months) after discontinuation of CyA. One patient had a relapse of ITP 4 years after CyA therapy was stopped. Side effects were moderate and transient, even in patients dependent on continued CyA treatment. CyA seems to represent reasonable salvage treatment in severe, potentially life-threatening, refractory ITP.<\/jats:p>","DOI":"10.1182\/blood.v99.4.1482","type":"journal-article","created":{"date-parts":[[2002,7,27]],"date-time":"2002-07-27T08:46:40Z","timestamp":1027759600000},"page":"1482-1485","update-policy":"https:\/\/doi.org\/10.1182\/blood.2019cm0000","source":"Crossref","is-referenced-by-count":74,"title":["Long-term salvage therapy with cyclosporin A in refractory idiopathic thrombocytopenic purpura"],"prefix":"10.1182","volume":"99","author":[{"given":"Giovanni","family":"Emilia","sequence":"first","affiliation":[{"name":"From the Department of Medical Sciences, Section of Internal Medicine and Hematology, University of Modena and Reggio Emilia, Modena, Italy."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Monica","family":"Morselli","sequence":"additional","affiliation":[{"name":"From the Department of Medical Sciences, Section of Internal Medicine and Hematology, University of Modena and Reggio Emilia, Modena, Italy."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mario","family":"Luppi","sequence":"additional","affiliation":[{"name":"From the Department of Medical Sciences, Section of Internal Medicine and Hematology, University of Modena and Reggio Emilia, Modena, Italy."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giuseppe","family":"Longo","sequence":"additional","affiliation":[{"name":"From the Department of Medical Sciences, Section of Internal Medicine and Hematology, University of Modena and Reggio Emilia, Modena, Italy."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roberto","family":"Marasca","sequence":"additional","affiliation":[{"name":"From the Department of Medical Sciences, Section of Internal Medicine and Hematology, University of Modena and Reggio Emilia, Modena, Italy."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giovanna","family":"Gandini","sequence":"additional","affiliation":[{"name":"From the Department of Medical Sciences, Section of Internal Medicine and Hematology, University of Modena and Reggio Emilia, Modena, Italy."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leonardo","family":"Ferrara","sequence":"additional","affiliation":[{"name":"From the Department of Medical Sciences, Section of Internal Medicine and Hematology, University of Modena and Reggio Emilia, Modena, Italy."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicola","family":"D'Apollo","sequence":"additional","affiliation":[{"name":"From the Department of Medical Sciences, Section of Internal Medicine and Hematology, University of Modena and Reggio Emilia, Modena, Italy."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leonardo","family":"Potenza","sequence":"additional","affiliation":[{"name":"From the Department of Medical Sciences, Section of Internal Medicine and Hematology, University of Modena and Reggio Emilia, Modena, Italy."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcello","family":"Bertesi","sequence":"additional","affiliation":[{"name":"From the Department of Medical Sciences, Section of Internal Medicine and Hematology, University of Modena and Reggio Emilia, Modena, Italy."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giuseppe","family":"Torelli","sequence":"additional","affiliation":[{"name":"From the Department of Medical Sciences, Section of Internal Medicine and Hematology, University of Modena and Reggio Emilia, Modena, Italy."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"234","reference":[{"key":"2020021221211651300_B1","doi-asserted-by":"crossref","first-page":"1207","DOI":"10.1056\/NEJM199411033311807","article-title":"Chronic idiopathic thrombocytopenic purpura.","volume":"331","author":"George","year":"1994","journal-title":"N Engl J Med."},{"key":"2020021221211651300_B2","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1182\/blood.V88.1.3.3","article-title":"Idiopathic thrombocytopenic purpura: a practice guideline developed by explicit methods for the American Society of Hematology.","volume":"88","author":"George","year":"1996","journal-title":"Blood."},{"key":"2020021221211651300_B3","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1111\/j.1365-2141.1991.tb04513.x","article-title":"Treatment of refractory idiopathic thrombocytopenic purpura in adults.","volume":"79","author":"Manoharan","year":"1991","journal-title":"Br J Haematol."},{"key":"2020021221211651300_B4","volume-title":"Wintrobe's Clinical Hematology.","author":"Lee","year":"1999","edition":"10th ed."},{"key":"2020021221211651300_B5","doi-asserted-by":"crossref","first-page":"1415","DOI":"10.1182\/blood.V82.5.1415.bloodjournal8251415","article-title":"Treatment of adult chronic autoimmune thrombocytopenic purpura with repeated high-dose intravenous immunoglobulin.","volume":"82","author":"Godeau","year":"1993","journal-title":"Blood."},{"key":"2020021221211651300_B6","first-page":"18","article-title":"Pathogenesis and management of chronic idiopathic thrombocytopenic purpura: an update.","volume":"71","author":"Yang","year":"2000","journal-title":"Int J Hematol."},{"key":"2020021221211651300_B7","doi-asserted-by":"crossref","first-page":"1402","DOI":"10.1056\/NEJM200105033441815","article-title":"Long-term outcomes after treatment for refractory immune thrombocytopenic purpura.","volume":"344","author":"McMillan","year":"2001","journal-title":"N Engl J Med."},{"key":"2020021221211651300_B8","first-page":"646a","article-title":"Humanized monoclonal anti-CD40 ligand antibody (hu5c8) rescue therapy of 15 adults with severe chronic refractory ITP [abstract].","volume":"94(suppl)","author":"Bussel","year":"1999","journal-title":"Blood."},{"key":"2020021221211651300_B9","doi-asserted-by":"crossref","first-page":"952","DOI":"10.1182\/blood.V98.4.952","article-title":"Rituximab chimeric anti-CD20 monoclonal antibody treatment for adults with chronic idiopathic thrombocytopenic purpura.","volume":"98","author":"Stasi","year":"2001","journal-title":"Blood."},{"key":"2020021221211651300_B10","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1016\/S0140-6736(05)61187-7","article-title":"Peripheral blood stem-cell transplantation for refractory autoimmune thrombocytopenic purpura.","volume":"349","author":"Lim","year":"1997","journal-title":"Lancet."},{"key":"2020021221211651300_B11","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1097\/00000441-198807000-00004","article-title":"Idiopathic thrombocytopenic purpura in the older adult patient.","volume":"296","author":"Guthrie","year":"1988","journal-title":"Am J Med Sci."},{"key":"2020021221211651300_B12","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1182\/blood.V77.1.31.31","article-title":"High risk of severe bleeding in aged patients with chronic idiopathic thrombocytopenic purpura.","volume":"77","author":"Cortelazzo","year":"1991","journal-title":"Blood."},{"key":"2020021221211651300_B13","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1111\/j.1600-0609.1987.tb01432.x","article-title":"Cyclosporine for the treatment of refractory idiopathic thrombocytopenic purpura.","volume":"38","author":"Velu","year":"1987","journal-title":"Eur J Hematol."},{"key":"2020021221211651300_B14","first-page":"36","article-title":"Management of chronic immune thrombocytopenic purpura in children and adults.","volume":"35(suppl 1)","author":"Blanchette","year":"1998","journal-title":"Semin Hematol."},{"key":"2020021221211651300_B15","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1046\/j.1365-2141.1996.4871026.x","article-title":"Long-term salvage treatment by cyclosporin in refractory autoimmune haematological disorders.","volume":"93","author":"Emilia","year":"1996","journal-title":"Br J Haematol."},{"key":"2020021221211651300_B16","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1111\/j.1365-2141.1985.tb07400.x","article-title":"Refractory idiopathic thrombocytopenic purpura (ITP) treated with cyclosporine.","volume":"60","author":"Kelsey","year":"1985","journal-title":"Br J Haematol."},{"key":"2020021221211651300_B17","first-page":"343a","article-title":"Low dose cyclosporine is beneficial in treating refractory ITP [abstract].","volume":"78(suppl)","author":"Siegel","year":"1991","journal-title":"Blood."},{"key":"2020021221211651300_B18","doi-asserted-by":"crossref","first-page":"690","DOI":"10.1016\/0002-9343(80)90419-2","article-title":"Fate of therapy failures in adult idiopathic thrombocytopenic purpura.","volume":"69","author":"Picozzi","year":"1980","journal-title":"Am J Med."},{"key":"2020021221211651300_B19","doi-asserted-by":"crossref","first-page":"2549","DOI":"10.1182\/blood.V97.9.2549","article-title":"Morbidity and mortality in adults with idiopathic thrombocytopenic purpura.","volume":"97","author":"Portielje","year":"2001","journal-title":"Blood."},{"key":"2020021221211651300_B20","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1046\/j.1365-2141.2001.02893.x","article-title":"Cyclosporin A for the treatment of patients with chronic idiopathic thrombocytopenic purpura refractory to corticosteroids or splenectomy.","volume":"114","author":"Kappers-Klunne","year":"2001","journal-title":"Br J Haematol."},{"key":"2020021221211651300_B21","doi-asserted-by":"crossref","first-page":"1725","DOI":"10.1056\/NEJM198912213212507","article-title":"Cyclosporine.","volume":"321","author":"Kahan","year":"1989","journal-title":"N Engl J Med."},{"key":"2020021221211651300_B22","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1111\/j.1432-2277.1999.tb00607.x","article-title":"Long-term maintenance of therapeutic cyclosporine levels leads to optimal graft survival without evidence of chronic nephrotoxicity.","volume":"12","author":"Lipkowitz","year":"1999","journal-title":"Transpl Int."},{"key":"2020021221211651300_B23","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1056\/NEJM199408113310604","article-title":"Long-term efficacy and safety of cyclosporine in renal-transplant recipients.","volume":"331","author":"Burke","year":"1994","journal-title":"N Engl J Med."}],"container-title":["Blood"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/ashpublications.org\/blood\/article-pdf\/99\/4\/1482\/1680403\/h8040201482.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/ashpublications.org\/blood\/article-pdf\/99\/4\/1482\/1680403\/h8040201482.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,2,12]],"date-time":"2020-02-12T21:21:26Z","timestamp":1581542486000},"score":1,"resource":{"primary":{"URL":"https:\/\/ashpublications.org\/blood\/article\/99\/4\/1482\/109980\/Longterm-salvage-therapy-with-cyclosporin-A-in"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2002,2,15]]},"references-count":23,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2002,2,15]]}},"URL":"https:\/\/doi.org\/10.1182\/blood.v99.4.1482","relation":{},"ISSN":["1528-0020","0006-4971"],"issn-type":[{"value":"1528-0020","type":"electronic"},{"value":"0006-4971","type":"print"}],"subject":[],"published":{"date-parts":[[2002,2,15]]}}}